Presentation
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific), Digital & Technology
Availability: FREE
- The problem: High investment with limited reach and high output that is short-lived.
- The objective: Capitalising on events to extend the value through sustained targeted engagement.
- The strategy: An end-to-end programme designed to be multicontent, multi-event & multi-channel.
- The evidence: Research and metrics that supports this approach and better outcomes.
Speaker
Tiberio Catania
Commercial Director
EPG Health Media, UK
Presentation
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific), Digital & Technology
Availability: FREE
A plethora of studies suggest that an astonishing 50 – 75% of all CRM implementations fail in some form. So we started our KOL CRM development programme with the assumption “why should ours be any different?” Our two-year case study highlights the many challenges we (vendor & our clients) encountered in the medical affairs context, our many failings, and the innovations we built to overcome them. We’ll also present a simple framework for Medical Affairs to help maximise the success of CRM implementations to boost external expert management.
Speaker
Sanjay Singhvi
Director, System Analytic, UK
Presentation
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific), Digital & Technology
Availability: FREE
- Assessment of viable online solutions to KOL stakeholder engagement in the pharmaceutical industry.
- Review major pharmaceutical company cases using web-based engagement solutions.
- Understand a variety of KOL engagement scenarios, shared learnings and best organisation practices for success.
Speaker
Peter Gannon
SVP Business Partnerships, Within3, Inc.
Presentation
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Global (non-specific)
Availability: FREE
Speaker
Jane Turner
Executive Director of Late Phase Research, INC Research, UK
Presentation
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Clinical, IT & Big Data, Global (non-specific)
Availability: FREE
- How companies can successfully navigate the EHR and secondarydata landscape.
- Designing and implement studies that reap the benefits of combining EDC and EHR data to answer key questions.
- Transforming the theory of real-world hybrid studies into reality.
Speaker
Angela Vinken
Sr. Director Observational Research
Parexel, Netherlands
Presentation
Related topics:
Pharmaceutical/Biotech, Market Access & HEOR, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Global (non-specific)
Availability: FREE
- Real-world data sources: What information needs can they address?
- Considerations, potential challenges and solutions.
- Types of hybrid studies with case studies.
- Chart reviews with additional data collection from patients.
- Recruitment of patients from registries for burden of disease outcomes.
- Linkage of different types of registries with the addition of patient interviews.
Speakers
William C. Maier
Chief Scientific Officer, Mapi Group, UK
Jennifer Eriksson
Associate Director, Real World Strategy & Analytics
Mapi Group, Sweden
Presentation
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific), Patient-Centricity & Care
Availability: FREE
- Why and when to run them?
- Benefits and pitfalls.
- Strategic considerations.
- Case study: The French ATU programme.
Speaker
Alexandre Malouvier
Director of Scientific Affairs, Late Phase Services
PRA Health Sciences
Presentation
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific)
Availability: FREE
Speakers
Rob Barker
CEO, Succinct Medical Communications, UK
James Turnbull
Digital Technical Director, Succinct Medical Communications, UK